40-week repeat-dose toxicity, toxicokinetics, and immunogenicity of efsubaglutide alfa following subcutaneous administration in cynomolgus monkeys

REGULATORY TOXICOLOGY AND PHARMACOLOGY · Published 2026-07-30 · DOI 10.1016/j.yrtph.2026.106192

Authors (7)

Yahao Wang, Yuyang Lei, Zhihong Wang, Liping Chen, Guirui Yan, Xiaodong Sun, Qinghua Wang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wang, Y., Lei, Y., Wang, Z., et al. (2026). 40-week repeat-dose toxicity, toxicokinetics, and immunogenicity of efsubaglutide alfa following subcutaneous administration in cynomolgus monkeys. REGULATORY TOXICOLOGY AND PHARMACOLOGY. https://doi.org/10.1016/j.yrtph.2026.106192

Related articles

• In silico prediction of Ames mutagenicity for organosilicon compounds: Exploring and enhancing chemical space boundaries · REGULATORY TOXICOLOGY AND PHARMACOLOGY · 2026 · Same journal
• Standardization and Assessment of Acute Dermal Toxicity of an Ayurvedic Medicine Brihat Somraji Taila in Sprague-Dawley rats · REGULATORY TOXICOLOGY AND PHARMACOLOGY · 2026 · Same journal
• Evaluating dosing guidelines for Ginkgo biloba: An evidence-based approach to standardisation · REGULATORY TOXICOLOGY AND PHARMACOLOGY · 2026 · Same journal
• Dietary intake and health risk characterization of cadmium, lead, and mercury in milkfish (Chanos chanos) and tilapia (Oreochromis spp.) from aquaculture farms surrounding Manila bay, Philippines · REGULATORY TOXICOLOGY AND PHARMACOLOGY · 2026 · Same journal
• Polycyclic aromatic hydrocarbon (PAH) contamination in clinical nutrition: Levels and associated health risks in enteral nutrition formulas · REGULATORY TOXICOLOGY AND PHARMACOLOGY · 2026 · Same journal
• Automated extraction of toxicological mechanism of action from PubMed literature using Large Language Models · REGULATORY TOXICOLOGY AND PHARMACOLOGY · 2026 · Same journal
• Derivation of an occupational exposure limit (OEL) for a potent bispecific protein—Blinatumomab (BLINCYTO®) · REGULATORY TOXICOLOGY AND PHARMACOLOGY · 2026 · Same journal
• Microplastics in intravenous fluids: Occurrence, characterization, and risk indicators · REGULATORY TOXICOLOGY AND PHARMACOLOGY · 2026 · Same journal
• Food enzyme safety: an extensive lineage of safe Aspergillus niger production strains · REGULATORY TOXICOLOGY AND PHARMACOLOGY · 2026 · Same journal
• Evaluation of subchronic toxicity, genotoxicity, and blood kinetics of 1,2-benzisothiazolin-3-one following oral administration · REGULATORY TOXICOLOGY AND PHARMACOLOGY · 2026 · Same journal